Screener
Crinetics Pharmaceuticals CRNX Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Crinetics Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect.
The source filing: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 4:21 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001658247-26-000040
FAQ
- What is Crinetics Pharmaceuticals's net change in cash?
- Crinetics Pharmaceuticals (CRNX) reported net change in cash of $12.81M in Q1 2026.
- How has Crinetics Pharmaceuticals's net change in cash changed year-over-year?
- Crinetics Pharmaceuticals's net change in cash increased by 107.5% year-over-year, from -$169.98M to $12.81M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.
Ask your AI about Crinetics Pharmaceuticals's net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude